METTL3 and breast carcinoma: METTL3 maintains m6A methylation homeostasis by methylating target mRNA and is involved in a variety of pathological processes, including colorectal carcinoma [17], breast cancer [18], chronic obstructive pulmonary disease [19], and DR [20].